Author

Sue Merson

Institute of Cancer Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Adrian LärkerydiD· 1 shared Bissan Al‐LazikaniiD· 1 shared Burga Ozer· 1 shared Colin S. CooperiD· 1 shared Costas MitsopoulosiD· 1 shared James A. CampbelliD· 1 shared Kaitlyn P Russell· 1 shared Nenning Dennis· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian LärkerydORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Distinct druggable biological processes in early-onset prostate cancer

Stephanie Schmidt, Zsofia Kote‐Jarai, Adrian Lärkeryd, Burga Ozer, Questa Karlsson, James A. Campbell, Sue Merson, Nenning Dennis, Steven Hazell, Costas Mitsopoulos, Colin S. Cooper, The ICGC-UK, Kaitlyn P Russell, Paul Workman, Rosalind A. Eeles, Bissan Al‐Lazikani

The paper uses machine learning to identify distinct biological processes and druggable targets in early-onset prostate cancer compared to late-onset prostate cancer.

bioRxiv · Apr 25, 2025 · PreprintCancer Biology